Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Druggable Targets of Squamous Cell Lung Cancer

Kim CH

  • KMID: 2320474
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):231-235.
Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adjuvant Treatment of Proper Endobronchial Management in Leiomyosarcoma

Kim SJ, Kim J, Park JH, Lee AR, Lee JK, Kim TM, Park YS

  • KMID: 2320478
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):250-255.
Endobronchial metastasis of leiomyosarcoma is rare, but it can cause life-threatening complications, such as massive hemoptysis, respiratory failure or even death. The development of new endoscopic modalities allows for effective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overview of ALK and ROS1 Rearranged Lung Cancer

Choi CM

  • KMID: 2320475
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):236-237.
Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Causes and Predictive Factors Associated with "Diagnosis Changed" Outcomes in Patients Notified as Tuberculosis Cases in a Private Tertiary Hospital

Kang BJ, Jo KW, Park TS, Yoo JW, Lee SW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS

  • KMID: 2320476
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):238-243.
BACKGROUND: The aim of our study was to evaluate the "diagnosis changed" rate in patients notified as tuberculosis (TB) on the Korean TB surveillance system (KTBS). METHODS: A total of 1,273...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis

Go SW, Kim BK, Lee SH, Kim TJ, Huh JY, Lee JM, Hah JH, Kim DW, Cho MJ, Kim TW, Kang JY

  • KMID: 2320479
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):256-259.
Imatinib mesylate is a targeted therapy that acts by inhibiting tyrosine kinase of the bcr-abl fusion oncoprotein, which is specific to chronic myeloid leukemia (CML), and the c-transmembrane receptor, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Elderly Man with Fatal Respiratory Failure after Eating a Poisonous Mushroom Podostroma cornu-damae

Jang J, Kim CH, Yoo JJ, Kim MK, Lee JE, Lim AL, Choi JH, Hyun IG, Shim JW, Shin HS, Han J, Seok SJ

  • KMID: 2320481
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):264-268.
A 73-year-old, previously healthy man presented with nausea, vomiting, diarrhea, dry mouth and febrile sensation 3 hours after eating boiled wild mushrooms. After admission, he showed progressive severe respiratory distress,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Invasive Pulmonary Aspergillosis after Influenza A Infection in an Immunocompetent Patient

Kwon OK, Lee MG, Kim HS, Park MS, Kwak KM, Park SY

  • KMID: 2320480
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):260-263.
Invasive aspergillosis has emerged as a major cause of life-threatening infections in immunocompromised patients. Recently, patients with chronic obstructive pulmonary disease, who have been receiving corticosteroids for a long period,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pleural Fluid Pentraxin-3 for the Differential Diagnosis of Pleural Effusions

Yeo CD, Kim JW, Cho MR, Kang JY, Kim SJ, Kim YK, Lee SH, Park CK, Kim SH, Park MS, Yim HW, Park JY

  • KMID: 2320477
  • Tuberc Respir Dis.
  • 2013 Dec;75(6):244-249.
BACKGROUND: Conventional biomarkers cannot always establish the cause of pleural effusions; thus, alternative tests permitting rapid and accurate diagnosis are required. The primary aim of this study is to assess...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr